We investigated the role of MELK in the growth of SCLC cells through two loss-of-function approaches, one targeting MELK expression with siRNA and the other targeting the MELK kinase activity with a small molecule inhibitor OTS167. This evidence concerns the gene MELK and small cell lung carcinoma.